Antibody diluent composition, antibody diluent and preparation method of antibody diluent

The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHEN YONG, WANG XIAOYA, YANG QINGHAI, JIANG NINGCHENG, ZHOU HONGHUI, GAO HUIRAN, CHEN HUILING
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHEN YONG
WANG XIAOYA
YANG QINGHAI
JIANG NINGCHENG
ZHOU HONGHUI
GAO HUIRAN
CHEN HUILING
description The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN109991408A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN109991408A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN109991408A3</originalsourceid><addsrcrecordid>eNrjZIh0zCvJTMpPqVRIycwpTc0rUUjOzy3IL84syczP01FIRJdNzEtRKChKLUgsSgSpUMhNLcnIT1HIT8NQysPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4p39DA0sLS0NTQwsHI2JUQMAQ1Y7bQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><source>esp@cenet</source><creator>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</creator><creatorcontrib>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</creatorcontrib><description>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190709&amp;DB=EPODOC&amp;CC=CN&amp;NR=109991408A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190709&amp;DB=EPODOC&amp;CC=CN&amp;NR=109991408A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHEN YONG</creatorcontrib><creatorcontrib>WANG XIAOYA</creatorcontrib><creatorcontrib>YANG QINGHAI</creatorcontrib><creatorcontrib>JIANG NINGCHENG</creatorcontrib><creatorcontrib>ZHOU HONGHUI</creatorcontrib><creatorcontrib>GAO HUIRAN</creatorcontrib><creatorcontrib>CHEN HUILING</creatorcontrib><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><description>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIh0zCvJTMpPqVRIycwpTc0rUUjOzy3IL84syczP01FIRJdNzEtRKChKLUgsSgSpUMhNLcnIT1HIT8NQysPAmpaYU5zKC6W5GRTdXEOcPXRTC_LjU4sLEpNT81JL4p39DA0sLS0NTQwsHI2JUQMAQ1Y7bQ</recordid><startdate>20190709</startdate><enddate>20190709</enddate><creator>CHEN YONG</creator><creator>WANG XIAOYA</creator><creator>YANG QINGHAI</creator><creator>JIANG NINGCHENG</creator><creator>ZHOU HONGHUI</creator><creator>GAO HUIRAN</creator><creator>CHEN HUILING</creator><scope>EVB</scope></search><sort><creationdate>20190709</creationdate><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><author>CHEN YONG ; WANG XIAOYA ; YANG QINGHAI ; JIANG NINGCHENG ; ZHOU HONGHUI ; GAO HUIRAN ; CHEN HUILING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN109991408A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>CHEN YONG</creatorcontrib><creatorcontrib>WANG XIAOYA</creatorcontrib><creatorcontrib>YANG QINGHAI</creatorcontrib><creatorcontrib>JIANG NINGCHENG</creatorcontrib><creatorcontrib>ZHOU HONGHUI</creatorcontrib><creatorcontrib>GAO HUIRAN</creatorcontrib><creatorcontrib>CHEN HUILING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHEN YONG</au><au>WANG XIAOYA</au><au>YANG QINGHAI</au><au>JIANG NINGCHENG</au><au>ZHOU HONGHUI</au><au>GAO HUIRAN</au><au>CHEN HUILING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibody diluent composition, antibody diluent and preparation method of antibody diluent</title><date>2019-07-09</date><risdate>2019</risdate><abstract>The invention firstly provides an antibody diluent composition. The antibody diluent composition is prepared from the components of polyvinyl pyrrolidone and magnesium adenosine triphosphate. Secondly, the invention provides an antibody diluent and a preparation method thereof. The antibody diluent is prepared from the components in parts by weight: 0.1-0.2 part of sodium dihydrogen phosphate, 3-3.2 parts of sodium hydrogen phosphate, 8.9-9.1 parts of sodium chloride, 9.5-10.5 parts of bovine serium albumin, 0.8-1.2 parts of Proclin 300, 0.9-1.1 parts of the Polyvinyl pyrrolidone, 0.4-0.6 partof the magnesium adenosine triphosphate, and 950-1050 parts of deionized water. According to the technical scheme, the polyvinyl pyrrolidone and the magnesium adenosine triphosphate are adopted as the components of the antibody diluent; and after the antibody diluent contains the combination of the polyvinyl pyrrolidone and the magnesium adenosine triphosphate, the non-specificity background staining of a polyclonal anti</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN109991408A
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title Antibody diluent composition, antibody diluent and preparation method of antibody diluent
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A40%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHEN%20YONG&rft.date=2019-07-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN109991408A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true